Skip to Content

Long-Haul COVID Symptoms Common, Rise With Severity of Illness

THURSDAY, April 22, 2021 -- For people who've suffered through a bout of COVID-19, their misery is too often not over. New research shows that a wide variety of "long-haul" symptoms are common, and the risk rises along with the severity of their case of COVID-19.

In what may be the largest such study to date, "the findings show that beyond the first 30 days of illness, substantial burden of health loss — spanning pulmonary and several extrapulmonary [non-respiratory] organ systems — is experienced by survivors of the acute phase of COVID-19," according to a team led by Dr. Ziyad Al-Aly, of the VA St. Louis Health Care System, in St. Louis, Mo.

As reported April 22 in the journal Nature, the new study tracked outcomes for over 73,000 non-hospitalized COVID-19 patients and almost 5 million without the illness. It also compared outcomes for nearly 14,000 Veterans Affairs (VA) patients hospitalized with COVID-19 against those of a similarly sized group of VA patients who'd been hospitalized with the seasonal flu.

The bottom line, said the researchers, is that in the six months after onset of their illness, COVID-19 survivors had a 59% increased risk for death compared to people who hadn't had the illness, and a 20% higher odds of needing to go back for some form of outpatient care.

The COVID-19 patients also had raised risks for "several conditions in almost every organ system," ranging from respiratory illnesses to nervous system symptoms, to mental health issues, heart troubles, gastrointestinal issues and simply "poor general well-being," the St. Louis team reported.

What's more, the odds that COVID-19 survivors would encounter long-haul symptoms rose along a "risk gradient that increased across [the] severity" of their initial symptoms as they encountered the illness, Al-Aly's team said.

Two experts not connected to the report weren't surprised.

The VA finding "falls well in line with previous reports from other U.S. and foreign reports" on long-haul COVID-19, said Dr. Thomas Gut, associate chair of medicine and director of ambulatory care services at Staten Island University Hospital, in New York City.

"At our Post-COVID Recovery Center, most people affected experience neurocognitive and respiratory complaints, which correlates well with the VA data," Gut said. "Although the article does not discuss specific complaints related to each organ system, it does demonstrate that post-COVID syndrome contains multiple organ involvement."

Dr. John Raimo is chair of medicine at Long Island Jewish Forest Hills, also in New York City. He applauded the study, saying it gave doctors and the public a deeper understanding of the issue.

"The fact that patients with more severe disease had an increased risk for future symptoms can allow physicians to better plan for and counsel patients regarding the need for regular follow-up," Raimo said.

And Gut said the findings don't bode well for health care systems going forward.

"It's worrying how many people are currently being affected, and how many more would potentially develop this syndrome as the pandemic continues globally," he added.

© 2021 HealthDay. All rights reserved.

Read this next

Ibuprofen, Similar Painkillers Won't Raise Risks for COVID Patients

MONDAY, May 10, 2021 -- Taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen doesn't make COVID-19 worse or more deadly, a new study finds. When the pandemic...

COVID Vaccines May Still Leave Organ Transplant Recipients Unprotected

MONDAY, May 10, 2021 -- Organ transplant recipients remain vulnerable to infection with the new coronavirus even after receiving both doses of two-dose vaccines, new research...

Health Highlights: May 10, 2021

CDC Revises Website Info on How COVID-19 Spreads The U.S. Centers for Disease Control and Prevention on Friday changed its website guidance on how coronavirus spreads,...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.